New criterion may improve identification of dementia risk in highly educated older adults

A different cutoff point on an existing mental function assessment may more effectively assess the risk of dementia in highly educated older adults, according to a report in the July issue of Archives of Neurology.

The most commonly administered screening test of cognitive (thinking, learning and memory) function is known as the mini-mental state examination (MMSE), according to background information in the article.

"The MMSE is used to screen patients for cognitive impairment, track changes in cognitive functioning over time and often to assess the effects of therapeutic agents on cognitive function," the authors write. "Performance on the MMSE is moderated by demographic variables, with scores decreasing with advanced age and less education." The maximum MMSE score is 30; a score of 24 or less is typically used to detect individuals with cognitive dysfunction.

Sid E. O'Bryant, Ph.D., of the Texas Tech University Health Sciences Center, and colleagues reviewed the MMSE scores of 1,141 participants (93 percent white, average age 75.9 years) in the Mayo Clinic Alzheimer Disease Research Center and Alzheimer Disease Patient Registry who reported having 16 or more years of education. These included 307 patients with dementia, 176 patients with mild cognitive impairment and 658 control patients without dementia.

With the traditional cut score of 24 on the MMSE, 89 percent of the participants were accurately classified by dementia status. This score had a sensitivity of 66 percent and a specificity of 99 percent for the detection of dementia, meaning that an individual with a score of 23 or lower would be correctly identified as having dementia 66 percent of the time and an individual with score of 24 or higher would be correctly diagnosed as not having dementia 99 percent of the time. Raising the cut score to 27 changed the sensitivity to 89 percent and the specificity to 78 percent, correctly classifying 90 percent of the participants.

"The current findings are not intended to encourage the diagnosis of cognitive impairment or dementia based on total MMSE scores alone," the authors write. "Instead, these results provide practitioners with revised criteria for appropriate management of highly educated older white patients.

Specifically, older patients who present with memory complaints (reported by themselves or others) who have attained a college degree or higher level of education and who score below 27 on the MMSE are at increased risk of cognitive dysfunction and dementia and should be referred for a comprehensive evaluation, including formal neuropsychological studies."

Provided by: JAMA and Archives Journals

Related stories:

10 percent of healthy people in study had injury from 'silent strokes'
A recent study found that about 10 percent of the apparently healthy middle-aged participants with no symptoms of stroke were injured from "silent strokes," researchers report in Stroke: Journal of the American Heart Association.


Simple test predicts 6-year risk of dementia
A simple test that can be given by any physician predicts a person’s risk for developing dementia within six years with 87 percent accuracy, according to a study led by researchers at San Francisco VA Medical Center (SFVAMC).
Loneliness associated with increased risk of Alzheimer's disease
Lonely individuals may be twice as likely to develop the type of dementia linked to Alzheimer's disease in late life as those who are not lonely, according to a study by researchers at the Rush Alzheimer's Disease Center. The study is published in the February issue of Archives of General Psychiatry.
Computer card game detects cognitive changes
A popular, computer-based card game is helping Oregon Health & Science University researchers monitor cognitive changes in the elderly, a new study shows.
Study confirms benefit of combination therapy for Alzheimer's disease
Extended treatment with Alzheimer's disease drugs can significantly slow the rate at which the disorder advances, and combination therapy with two different classes of drugs is even better at helping patients maintain their ability to perform daily activities. Results from the first long-term study of the real-world use of Alzheimer's drugs, published by researchers from Massachusetts General Hospital in the July/September issue of Alzheimer Disease and Associated Disorders, support a level of effectiveness that may not be immediately apparent to patients or their family members.
Is 95 the new 75? Or even 35?
Gordon Bern doubled his treadmill time in the Leisure World gym so he could walk on uneven cobblestones during his first visit to Europe over the summer. Such are travel preparations at 95.
A blood marker may indicate Alzheimer’s risk
A simple blood test capable of predicting if a person might develop Alzheimer’s disease is within sight, and could eventually be used to help scientists reverse onset of the disease in those most at risk.
Inflammatory response to infection and injury may worsen dementia
Inflammation in the brain resulting from infection or injury may accelerate the progress of dementia, research funded by the Wellcome Trust suggests. The findings, published this week in the journal Biological Psychiatry, may have implications for the treatment and care of those living with dementia.

News discussion:

Medicine & Health news